Coverage Policy Development for Personalized Medicine: Private Payer Perspectives on Developing Policy for the 21-Gene Assay

  • J. R. Trosman, S. L. Van Bebber, K. A. Phillips
  • Journal of Oncology Practice, September 2010, American Society of Clinical Oncology (ASCO)
  • DOI: 10.1200/jop.000075

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication

The following have contributed to this page: Dr Julia R. Trosman